Related Experiment Video
Updated: Aug 28, 2025
08:14
A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model
Published on: February 28, 2018
8.9K
Interaction between gut microbiota and tumour chemotherapy
Le Liu1,2, Yuping Bai1, Lin Xiang1
1The Second Clinical Medical College of Lanzhou University, Lanzhou, 730000, China.
Summary
The gut microbiome influences chemotherapy effectiveness and side effects in cancer patients. Probiotic supplementation may offer a strategy for personalized cancer treatment by modulating this interaction.
Area of Science:
- Oncology
- Microbiology
- Pharmacology
Background:
- Chemotherapy is crucial for cancer treatment, but patient sensitivity and drug resistance pose significant clinical challenges.
- The human gut microbiome's role in disease diagnosis and treatment is increasingly recognized.
- Gut microbiota can modulate the tumor microenvironment, impacting chemotherapy efficacy and toxicity.
Purpose of the Study:
- To elucidate the mechanisms by which gut microbiota influences chemotherapy.
- To explore the therapeutic potential of probiotic supplementation in cancer treatment.
- To establish a foundation for personalized treatment strategies in malignant tumors.
Main Methods:
- Review of current research on gut microbiota and chemotherapy interactions.
- Analysis of mechanisms involving gut microbiota in regulating the tumor microenvironment.
- Evaluation of studies on probiotic interventions and their effects on chemotherapy outcomes.
Main Results:
- Gut microbiota significantly impacts chemotherapy efficacy and toxicity through various pathways.
- Specific microbial compositions can either enhance or diminish treatment responses.
- Probiotics show potential in mitigating chemotherapy-induced toxicity and improving treatment outcomes.
Conclusions:
- Gut microbiota is a key factor in chemotherapy response and toxicity.
- Targeting the gut microbiome, potentially with probiotics, offers a promising avenue for personalized cancer therapy.
- Further research is needed to fully leverage gut microbiota for optimizing cancer treatment strategies.
More Related Videos
Related Concept Videos
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
01:27Tumor Immunotherapy
643
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
643
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
250
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
250
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
361
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
361